全文获取类型
收费全文 | 16243篇 |
免费 | 1066篇 |
国内免费 | 61篇 |
专业分类
耳鼻咽喉 | 173篇 |
儿科学 | 454篇 |
妇产科学 | 212篇 |
基础医学 | 1953篇 |
口腔科学 | 375篇 |
临床医学 | 1578篇 |
内科学 | 3718篇 |
皮肤病学 | 289篇 |
神经病学 | 1701篇 |
特种医学 | 487篇 |
外科学 | 2267篇 |
综合类 | 194篇 |
一般理论 | 14篇 |
预防医学 | 1544篇 |
眼科学 | 454篇 |
药学 | 932篇 |
中国医学 | 15篇 |
肿瘤学 | 1010篇 |
出版年
2023年 | 92篇 |
2022年 | 135篇 |
2021年 | 352篇 |
2020年 | 186篇 |
2019年 | 327篇 |
2018年 | 355篇 |
2017年 | 288篇 |
2016年 | 267篇 |
2015年 | 330篇 |
2014年 | 513篇 |
2013年 | 682篇 |
2012年 | 1175篇 |
2011年 | 1180篇 |
2010年 | 658篇 |
2009年 | 610篇 |
2008年 | 1093篇 |
2007年 | 1234篇 |
2006年 | 1173篇 |
2005年 | 1143篇 |
2004年 | 1088篇 |
2003年 | 950篇 |
2002年 | 935篇 |
2001年 | 121篇 |
2000年 | 106篇 |
1999年 | 116篇 |
1998年 | 195篇 |
1997年 | 140篇 |
1996年 | 108篇 |
1995年 | 109篇 |
1994年 | 95篇 |
1993年 | 105篇 |
1992年 | 85篇 |
1991年 | 68篇 |
1990年 | 54篇 |
1989年 | 63篇 |
1988年 | 47篇 |
1987年 | 44篇 |
1986年 | 65篇 |
1985年 | 67篇 |
1984年 | 92篇 |
1983年 | 95篇 |
1982年 | 97篇 |
1981年 | 112篇 |
1980年 | 101篇 |
1979年 | 41篇 |
1978年 | 58篇 |
1977年 | 36篇 |
1976年 | 42篇 |
1975年 | 38篇 |
1974年 | 38篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
Joel G. Fletcher James M. Kofler John A. Coburn David H. Bruining Cynthia H. McCollough 《Abdominal imaging》2013,38(1):22-31
Awareness of and communication about issues related to radiation dose are beneficial for patients, clinicians, and radiology departments. Initiating and facilitating discussions of the net benefit of CT by enlisting comparisons to more familiar activities, or by conveying that the anticipated radiation dose to an exam is similar to or much less than annual background levels help resolve the concerns of many patients and providers. While radiation risk estimates at the low doses associated with CT contain considerable uncertainty, we choose to err on the side of safety by assuming a small risk exists, even though the risk at these dose levels may be zero. Thus, radiologists should individualize CT scans according to patient size and diagnostic task to ensure that maximum benefit and minimum risk is achieved. However, because the magnitude of net benefit is driven by the potential benefit of a positive exam, radiation dose should not be reduced if doing so may compromise making an accurate diagnosis. The benefits and risks of CT are also highly individualized, and require consideration of many factors by patients, clinicians, and radiologists. Radiologists can assist clinicians and patients with understanding many of these factors, including test performance, potential patient benefit, and estimates of potential risk. 相似文献
104.
105.
Stephen R. Thomas Ronald G. Pratt Ronald W. Millard R. C. Samaratunga Yoseph Shiferaw Leland C. Clark Richard E. Hoffmann 《Journal of magnetic resonance imaging : JMRI》1994,4(4):631-635
Oxygen-sensitive F-19 magnetic resonance imaging of perfluorocarbon compounds requires that fluorocarbon T1 changes correlate with the local Po2 and not with the composition of the surrounding aqueous phase. The influence of various bioconstituents and paramagnetic ions within the aqueous phase on the F-19 fluorocarbon phase T1 for PFC emulsions was evaluated at 0.14 and 0.66 T. T1 was measured for FC-43, perflubron, and a fluorinated surfactant. Controlled variables introduced in the aqueous phase included annex solution constituents, blood, pH changes, and Gd-DTPA. For a constant Po2, the F-19 T1s were independent of the emulsion constituents, blood concentration, and pH. For FC-43 and perflubron, F-19 T1 was independent of the Gd-DTPA concentration, while the aqueous phase T1 decreased by more than an order of magnitude. XMO-10 (smallest emulsion particle size) showed a slight decrease in F-19 T1 with increasing Gd-DTPA concentration at 0.66 T. 相似文献
106.
PURPOSE: We studied preoperative variables in a contemporary series of men who underwent nonnerve sparing radical prostatectomy in an effort to establish criteria that would predict side specific extraprostatic extension (EPE) of cancer. MATERIALS AND METHODS: We reviewed the records of 430 patients who underwent radical prostatectomy for localized prostate cancer with no prior therapy between 1996 and 1998, and for whom we had at least sextant biopsy information. We evaluated biopsy data (Gleason score, maximum length of cancer in positive cores, percent of cancer per involved core, proportion of positive biopsy cores, tumor location and number of positive biopsy cores) and correlated these findings with EPE at the neurovascular bundle and posterior lateral (NVB/PL) region. RESULTS: We found that a higher number of positive cores, a higher biopsy Gleason score on a side, a positive core at the basal region, 50% or greater tumor in the core or a maximum tumor length of 7 mm or greater increased the likelihood that EPE was present at the NVB/PL region on the corresponding side of the prostate. On multivariate analysis maximum tumor length 7 mm or greater and positive basal core location were the strongest independent predictors of EPE at the NVB/PL region on a given side (p <0.0001 and 0.002, respectively). CONCLUSIONS: Excluding any patient with 1 positive biopsy core with a maximum tumor length of 7 mm or greater plus a positive basal core of any tumor length and grade can decrease the risk of EPE at the NVB/PL region to approximately 10%. 相似文献
107.
Benefits of resection for metachronous lung cancer 总被引:2,自引:0,他引:2
Battafarano RJ Force SD Meyers BF Bell J Guthrie TJ Cooper JD Patterson GA 《The Journal of thoracic and cardiovascular surgery》2004,127(3):836-842
OBJECTIVES: The benefits of resection for metachronous lung cancer are not well described. The objective of this study was to evaluate the safety and efficacy of surgical resection for metachronous lung cancers. METHODS: We reviewed the charts of all patients who underwent a second resection for a metachronous lung cancer from July 1, 1988, to December 31, 2002. Type of resection, operative morbidity, mortality, and survival by stage were analyzed. Survival was determined by using the Kaplan-Meier survival method. All patients were pathologically staged by using the 1997 American Joint Committee on Cancer standards. RESULTS: Pulmonary resections were performed in 69 patients who had undergone a previous resection. The mean interval between the first and second resection was 2.4 +/- 2.5 years. Seventy-three percent of patients presented with stage I cancers, 9% with stage II cancers, and 17% with stage III cancers. Lobectomy and wedge resection were performed with equal frequency (42% each) for the metachronous cancers. Operative mortality for the second resection was 5.8%. The mean follow-up after the second resection was 37 months. Overall 5-year actuarial survival for the entire group after the second resection was 33.4%. CONCLUSIONS: Operations for metachronous cancers provided survival that approximated the expected survival for lung cancer. Surgical intervention should be considered as a safe and effective treatment for resectable metachronous lung cancer in patients with adequate physiologic pulmonary reserve. 相似文献
108.
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the use of transmyocardial revascularisation (TMR) in addition to coronary artery bypass grafting (CABG) is of benefit in patients with ischaemic heart disease with areas of ungraftable myocardium. Altogether 233 papers were found using the reported search, of which 9 represented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses were tabulated. We conclude that while the society of thoracic surgeons now recommend TMR+CABG, and the available studies indicate that mortality is not increased by this additional procedure, it is currently not clear whether TMR reduces symptoms of angina in addition to CABG alone. 相似文献
109.
A Linkermann F De Zen J Weinberg U Kunzendorf S Krautwald 《Nephrology, dialysis, transplantation》2012,27(9):3412-3419
Programmed cell death (PCD) had been widely used synonymously to caspase-mediated apoptosis until caspase-independent cell death was described. Identification of necrosis as a regulated process in ischaemic conditions has recently changed our understanding of PCD. At least three pathways of programmed necrosis (PN) have been identified. First, receptor-interacting protein kinase 3 (RIP3)-dependent necroptosis causes organ failure following stroke, myocardial infarction and renal ischaemia/reperfusion injury. Necroptosis can be mediated either by a large intracellular caspase-8-containing signalling complex called the ripoptosome or by the RIP1-/RIP3-containing necroptosome and is controlled by a caspase-8/FLICE inhibitory protein(long) heterodimer at least in the latter case. Second, mitochondrial permeability transition mediates apoptotic or necrotic stimuli and depends on the mitochondrial protein cyclophilin D. The third PN pathway involves the poly(ADP-ribose) polymerase-calpain axis that contributes to acute kidney injury (AKI). Preclinical interference with the PN pathways therefore raises expectations for the future treatment of ischaemic conditions. In this brief review, we aim to summarize the clinically relevant PCD pathways and to transfer the basic science data to settings of AKI. We conclude that pathologists were quite right to refer to ischaemic kidney injury as 'acute tubular necrosis'. 相似文献
110.
Joel M. Baumgartner Alyssa Krasinskas Mustapha Daouadi Amer Zureikat Wallis Marsh Kenneth Lee David Bartlett A. James Moser Herbert J. Zeh III 《Journal of gastrointestinal surgery》2012,16(6):1152-1159